Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Search

Top

Back to Contracts

Funding Agreement

Awarded

GA590295Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This Funding Agreement, identified by solicitation number GA590295, provides financial support for a national program managed by the Australian Government's Organ and Tissue Authority. The primary objective of the initiative is to enhance transplantation opportunities by increasing the rates of organ and tissue donation across the country. The program is administered by the Organ and Tissue Authority, with the designated place of performance located in Adelaide, Australia. Interested parties or those seeking further information can coordinate with the Grants Officer via the provided corporate contact email.

General Info

Australian Government funding for Organ and Tissue Authority to increase national donation rates.

Agency

Australian Government → Organ and Tissue Authority

Contract Value

$3,169,694

NAICS

621991 - Blood and Organ Banks

Place of Performance

Adelaide, SA, 5000, AUS

Set-Aside

NONE

Awardee

State of South Australia as represented by the Minister for Health and Wellbeing acting through the South Australian Department for Health and Wellbeing

Award Issued Date

10/21/2026, 12:00:00 AM UTC

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseAwarded

PostedOct 21

Contract opportunity posted

AwardedOct 21

Contract was awarded

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyAustralian Government → Organ and Tissue Authority

Contacts1 person available

OfficeN/A

Organization / AgencyAustralian Government → Organ and Tissue Authority

Office AddressN/A

Contacts

Grants Officer

contact@example.gov

Full Description

Show more

Funding to support the agreed national program to improve the opportunities for transplantation through increased organ and tissue donation.

Similar Contracts

Same NAICS industry code

BPA - Blood Transfusion Services

Solicitation # FA860127Q0015

Solicitation FA8601-27-Q-0015 is a combined synopsis and request for quotation for a Blanket Purchase Agreement (BPA) to provide blood components and reference lab transfusion testing services for the 88th Medical Group at Wright Patterson AFB, Ohio. The contract supports inpatient, outpatient, and emergency care, requiring the contractor to maintain FDA licensing, AABB standard compliance, and 24/7 availability, including a mission-critical one-hour turnaround for STAT deliveries. The BPA has a master dollar limit of 425,000.00 dollars, with individual purchase calls capped at 85,000.00 dollars, and a period of performance running from December 4, 2026, to October 5, 2031. Award will be made using the Lowest Price Technically Acceptable (LPTA) method to the lowest-priced offeror that meets all solicitation requirements and receives an acceptable rating for technical capability. This acquisition is not set aside for small businesses and falls under NAICS code 621991. Offerors must be registered in the System for Award Management (SAM) and meet a mandatory minimum CMMC Level 1 assessment. Quotes must be submitted electronically to the designated contract specialist and contracting officer by the specified deadline, including a completed Required Information Sheet and detailed descriptions of services to be considered for award.

FA8601 Aflcmc Pzio

POSTED

DEADLINE

Transplant Center Patient Registration Fees

Solicitation # 2140267

SUNY Upstate Medical University has established a procurement for the payment of monthly transplant center Patient Registration Fees for the period of October 1, 2026, through September 30, 2027. These fees are payable to the Health Resources Services Administration of the US Department of Health and Human Services for transplant patients registered at the university. The contract is designated as a sole source exemption granted by the Office of the State Comptroller in accordance with Section 144(2)(e) of the Economic Development Law, which allowed the university to bypass the initial publication of the opportunity in the procurement opportunities newsletter. The agreement is managed by Hannah Carrillo, Assistant Contract Administrator at SUNY Upstate Medical University in Syracuse, New York. While the specific contract value and unit pricing are not disclosed in the solicitation notice, the performance period is set for one year. This special notice procurement is identified by solicitation number 2140267 and is categorized as a procurement exempt from advertising.

State University of New York (SUNY)

POSTED

DEADLINE

6505--Human Blood and Blood Products

Solicitation # 36C25727Q0049

The Department of Veterans Affairs, Network Contracting Office 17, intends to award a single-award, firm-fixed-price Indefinite Delivery/Indefinite Quantity (IDIQ) contract to the South Texas Blood and Tissue Center. This procurement is for the supply and delivery of human blood and blood products, as well as guidance in clinical pathology procedures, to support the Audie L. Murphy Veterans Health Care Center within the South Texas Veterans Health Care System in San Antonio, Texas. The government is pursuing this as a sole source procurement under the authority of 41 U.S.C. 3304(a)(1) and FAR 6.103-1, asserting that only one responsible source can satisfy the agency's requirements. The contractor must maintain AABB and College of American Pathologists (CAP) accreditation and hold an unrevoked U.S. license from the FDA Bureau of Biologics. Key operational requirements include 24/7/365 availability and a tiered delivery system: STAT orders must be delivered within 60 minutes, ASAP orders within 2 hours, and routine orders within 24 hours. All products must be collected via closed systems under aseptic conditions, labeled according to the ABO Blood Group System and Rh type, and transported in compliance with FDA, AABB, and DOT regulations to ensure proper temperature maintenance. Acceptance of deliveries is based on STVHCS Blood Bank criteria, including physical appearance, contamination checks, and specific shelf-life minimums for red blood cells, plasma, and cryoprecipitate.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

Solicitation # RFA-CA-28-004

The National Cancer Institute (NCI) has issued a Limited Competition Notice of Funding Opportunity (RFA-CA-28-004) to support the continuation of two critical biospecimen banking resources: the National Clinical Trials Network (NCTN) Biobanks and the Early-Phase and Experimental Clinical Trials (EET) Biobank. The primary objective is to maintain these national resources for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens. These resources facilitate translational cancer research, biomarker development, and validation by providing essential specimens from NCI-funded clinical trials. The NCI intends to fund approximately six awards for fiscal year 2027, with a total estimated funding of 19 million dollars and a maximum budget of 3 million dollars in direct costs per year for a requested project period of six years. Applications will be evaluated through the NIH peer-review system based on scientific and technical merit, significance, and the adequacy of the institutional environment. Key requirements for applicants include maintaining active registrations in SAM, eRA Commons, and Grants.gov, as well as providing specific documentation regarding the current scale of operations, accomplishments, and standard operating procedures. Awardees must adhere to NCI Best Practices for Biospecimen Resources, federal human subjects regulations under 45 CFR 46, and strict cybersecurity incident reporting protocols, including notification of incidents within 48 hours of discovery. The scope of work includes managing secure informatics systems, providing specimen collection kits, and ensuring the availability of annotated biospecimens for authorized investigators.

National Institutes Of Health

POSTED

DEADLINE

Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

Solicitation # RFA-CA-28-004

The National Cancer Institute is issuing a limited competition Notice of Funding Opportunity, solicitation RFA-CA-28-004, to support the continuation of two critical biospecimen banking resources. These resources include the National Clinical Trials Network Biobanks, which support the NCTN and the Community Oncology Research Program, and the Early-Phase and Experimental Clinical Trials Biospecimen Bank, which supports the ETCTN and other early-phase experimental trials. The primary objective is to maintain national infrastructure for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens to enable translational cancer research, biomarker development, and the study of drug response and resistance. Eligible organizations must submit applications by February 12, 2027, to be considered for funding. All submissions will undergo a standard NIH peer-review process, and only meritorious applications will be selected. These banks are essential for linking biospecimens to clinical outcome data from large multi-site trials and supporting the development of novel cancer therapies through pharmacokinetic and pharmacodynamic analyses.

National Cancer Institute

POSTED

DEADLINE

Kidney Transplant Exemption

Solicitation # 2139277

SUNY Downstate Health Sciences University has issued a notice for a single source exemption under solicitation number 2139277 to support its Kidney Transplant Program. This procurement action, which was posted on September 22, 2026, follows the approval of a CRER request by the Office of the State Comptroller on September 18, 2026. The scope of the procurement is specifically tied to the Kidney Transplant Unit having received a kidney for its program. The performance for this action is located at 450 Clarkson Avenue, Brooklyn, New York. As this is a notice of a procurement exempt from advertising, there are no competitive evaluation factors, listed contract terms, or specified contract values. The primary point of contact for this action is Purchase Associate Joanne Fraser.

State University of New York (SUNY)

POSTED

about 1 month ago

DEADLINE

Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (R24 Clinical Trial Not Allowed)The National Institutes of Health is seeking a Tissue Procurement Center to support the Somatic Mosaicism across Human Tissues (SMaHT) Network. The primary goal of this initiative is to advance the understanding of biological processes and disease mechanisms driven by somatic mutations in human tissues. The center will be responsible for the collection, processing, storage, and distribution of high-quality human tissue specimens to enable functional analyses and the characterization of somatic mosaicism. The program aims to expand its existing foundation of 150 healthy donors by procuring tissues from at least 50 additional healthy individuals, reaching a total of 200. Additionally, the center will collect up to 10 special tissue cohorts, which may include clinically relevant samples, tissues suitable for culture, or organs requiring specialized handling. The awardee will collaborate with other SMaHT Stage 2 initiatives to ensure that all samples are sufficient for production-level assays.

National Institutes Of Health

POSTED

about 2 months ago

DEADLINE

Blood SamplesThe Department of Commerce is seeking to procure healthy GMP-grade Leukopaks and fresh healthy whole blood samples. These biological materials will be utilized for forensic DNA testing, the production of standard reference materials, the execution of inter-laboratory studies, and the publication of allele frequencies. This requirement is listed as a forecast with the place of performance located in Gaithersburg. The procurement falls under NAICS code 621991, and interested parties may coordinate with the designated point of contact, Daniel Dender, or the Office of Small and Disadvantaged Business Utilization.

POSTED

DEADLINE

Inpatient and Off-Site Facility CoordinationThis subcontract, titled Inpatient and Off-Site Facility Coordination, is issued by the Department of Justice under the agency Fao. The primary scope of work involves the arrangement and monitoring of off-site hospitalizations, diagnostic procedures, and specialty inpatient care, with a specific focus on managing the associated transport logistics. The contract is categorized under NAICS code 621991 and is designated for performance in Pine Knot, Kentucky, 42635. It was posted on August 14, 2026, and is available for further review through the official government workspace link.

POSTED

DEADLINE

Mobile Health Unit OperationsThe contract titled Mobile Health Unit Operations seeks a subcontractor to manage the operation and maintenance of mobile units tasked with delivering vision, dental, and hearing services to underserved communities across the region. These mobile units will serve as critical access points for essential health care, ensuring that populations with limited transportation or geographic barriers receive timely and consistent medical attention. The work involves the full lifecycle management of the units, including routine maintenance, repairs, staffing coordination, logistics, and compliance with health and safety standards to guarantee reliable service delivery. The contract is categorized as a subcontract under NAICS code 621991 and is solicited by the Houston-Galveston Area Council through the Texas SmartBuy platform. The solicitation was posted on July 22, 2026, with a response deadline of July 29, 2027, providing over a year for prospective vendors to prepare proposals. The place of performance spans the region served by the council, though exact locations are not specified, indicating flexibility in service deployment based on community need. While details on set-aside status and point of contact are unavailable, the focus remains on operational excellence and equitable access to preventive and diagnostic health services in areas lacking permanent clinical infrastructure.

HOUSTON-GALVESTON AREA COUNCIL

POSTED

DEADLINE

Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24)The National Mesothelioma Virtual Bank, managed by the Centers for Disease Control and Prevention under the Department of Health and Human Services, is a translational research initiative focused on advancing biomedical research for malignant mesothelioma. This forecast opportunity aims to expand the existing virtual registry and tissue bank by integrating additional biospecimens, such as frozen tumor tissues, blood, DNA, and protein samples, with comprehensive demographic and clinical data. By providing a shared repository of genomic, transcriptomic, and proteomic data, the project supports the identification of early disease signs, the development of prognostic biomarkers, and the creation of improved treatment options. The primary objective is to enhance the bank's capacity as a critical resource for the clinical science community and biomedical researchers. This effort is categorized under NAICS code 621991 and is designed to facilitate the sharing of high-quality specimens and data to accelerate breakthroughs in mesothelioma research.

Centers For Disease Control And Prevention

POSTED

DEADLINE

Deceased Donor Organ Recovery ServicesThis contract involves the clinical and logistical coordination necessary for the recovery of deceased donor organs at hospital settings. The scope includes organizing surgical teams and managing donor cases to ensure the efficient and effective retrieval of organs for transplant purposes. The services are designed to support hospital operations and facilitate timely donor organ recovery, which is critical for successful transplantation outcomes. Awarded by the Department of Veterans Affairs under the 244-NETWORK Contract Office 4, the contract is classified under the NAICS code 621991, which pertains to ambulatory health care services. Although specific details such as the place of performance, solicitation number, and point of contact are not provided, the contract clearly targets the provision of specialized clinical support in organ procurement, reinforcing the agency’s commitment to healthcare and transplant services.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS